NeoGenomics, Inc.(NASDAQ : NEO)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
Health Services » Medical Or Nursing Services
|GH||Guardant Health, Inc.||3.99%||132.05||0.0%||$105.00m|
|OPCH||Option Care Health, Inc.||0.78%||25.75||0.0%||$93.34m|
|OSH||Oak Street Health, Inc.||1.55%||52.54||0.0%||$90.98m|
|CANO||Cano Health, Inc.||-0.32%||15.39||0.0%||$81.40m|
|FLGT||Fulgent Genetics, Inc.||6.53%||91.71||0.6%||$45.45m|
|ONEM||1Life Healthcare, Inc.||6.12%||25.16||0.0%||$39.11m|
|LHCG||LHC Group, Inc.||2.04%||168.97||2.9%||$37.28m|
|ACHC||Acadia Healthcare Co., Inc.||3.13%||61.22||26.8%||$27.00m|
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.